Psychiatrie-Leitlinien

49 aktuelle Psychiatrie-Leitlinien von nationalen Behörden, europäischen Fachgesellschaften und HTA-Institutionen, über 15 Quellgruppen. eUvidence verankert Psychiatrie-Antworten an diesen Leitlinien; jeder Eintrag verlinkt auf die eigene Seite der herausgebenden Institution.

Europäische Fachgesellschaften· 8

• Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders

  WHO · World Health Organization · 2023

• WFSBP Guidelines for Biological Treatment of Schizophrenia, Part 3: Update 2015 — Management of Special Circumstances: Depression, Suicidality, Substance Use Disorders and Pregnancy and Lactation

  WFSBP · World Federation of Societies of Biological Psychiatry · 2015

• WFSBP Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the Long-term Treatment of Schizophrenia and Management of Antipsychotic-induced Side Effects

  WFSBP · World Federation of Societies of Biological Psychiatry · 2013

• WFSBP Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the Acute and Continuation Treatment of Unipolar Depressive Disorders

  WFSBP · World Federation of Societies of Biological Psychiatry · 2013

• WFSBP Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the Acute Treatment of Schizophrenia and the Management of Treatment Resistance

  WFSBP · World Federation of Societies of Biological Psychiatry · 2012

• The European Psychiatric Association (EPA) Guidance on Suicide Treatment and Prevention

  EPA · European Psychiatric Association · 2012

• WFSBP Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the Treatment of Acute Bipolar Depression

  WFSBP · World Federation of Societies of Biological Psychiatry · 2010

• WFSBP Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the Treatment of Acute Mania

  WFSBP · World Federation of Societies of Biological Psychiatry · 2009

Belgien· 1

• Management of major depression: pharmacotherapy and psychotherapy

  KCE · Belgian Health Care Knowledge Centre · 2014

Dänemark· 4

• National Clinical Recommendation on Non-pharmacological Treatment of ADHD in Adults

  SST · Danish Health Authority · 2025 · recommendation

• National Clinical Recommendation on Combination Treatment with Antipsychotics and ADHD Medication in Patients with Primary Psychotic Disorder

  SST · Danish Health Authority · 2024 · recommendation

• National Clinical Recommendation on the Use of Sedative Medicines for Short-term Symptom Relief of New-onset Anxiety and Agitation in Adults

  SST · Danish Health Authority · 2023 · recommendation

• National Clinical Guideline for the Treatment of Anxiety Disorders in Adults

  SST · Danish Health Authority · 2021

Finnland· 4

• Schizophrenia

  Kaypa hoito · Finnish Medical Society Duodecim and the Finnish Psychiatric Association · 2024

• Schizophrenia

  Kaypa hoito · Finnish Medical Society Duodecim and the Finnish Psychiatric Association · 2020

• Anxiety Disorders

  Kaypa hoito · Finnish Medical Society Duodecim, the Finnish Psychiatric Association and the Finnish Association of Adolescent Psychiatry · 2018

• Alcohol Abuse

  Kaypa hoito · Finnish Medical Society Duodecim and the Finnish Society of Addiction Medicine · 2015

Frankreich· 4

• Neurodevelopmental Disorder / ADHD: Diagnosis and Therapeutic Interventions in Children and Adolescents

  HAS · Haute Autorité de Santé · 2024 · recommendation

• Autism Spectrum Disorder: Interventions and Life Pathway of Adults

  HAS · Haute Autorité de Santé · 2018 · good practice guide

• Management of a Characterised Depressive Episode in Adults in Primary Care

  HAS · Haute Autorité de Santé · 2017 · recommendation

• Patient with a Bipolar Disorder: Detection and Initial Management in Primary Care

  HAS · Haute Autorité de Santé · 2015 · recommendation

Deutschland· 5

• S3 Guideline Schizophrenia

  DGPPN · Deutsche Gesellschaft für Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde · 2025

• National Care Guideline Unipolar Depression

  DGPPN · Deutsche Gesellschaft für Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde · 2022

• S3 Guideline Obsessive-Compulsive Disorders

  DGPPN · Deutsche Gesellschaft für Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde · 2022

• S3 Guideline Treatment of Anxiety Disorders

  DGPPN · Deutsche Gesellschaft für Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde · 2021

• S3 Guideline for Diagnosis and Treatment of Bipolar Disorders

  DGPPN · Deutsche Gesellschaft für Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde / Deutsche Gesellschaft für Bipolare Störungen · 2019

Irland· 2

• Appropriate Prescribing of Psychotropic Medication for Non-Cognitive Symptoms in People with Dementia: National Clinical Guideline No. 21

  NCEC · National Clinical Effectiveness Committee, Department of Health · 2019

• Appropriate Prescribing of Psychotropic Medication for Non-Cognitive Symptoms in People with Dementia — National Clinical Guideline No. 21

  NCEC · National Clinical Effectiveness Committee, Department of Health · 2019

Italien· 1

• Diagnosis and Treatment of Adults with Autism Spectrum Disorder

  ISS · Istituto Superiore di Sanita · 2023

Niederlande· 4

• Care Standard Bipolar Disorders

  GGZ Standaarden · GGZ Standaarden (Akwa GGZ) · 2023

• Care Standard Depressive Disorders

  GGZ Standaarden · GGZ Standaarden (Akwa GGZ) · 2018

• Care Standard Psychosis

  GGZ Standaarden · GGZ Standaarden (Akwa GGZ) · 2017

• Care Standard Anxiety Complaints and Anxiety Disorders

  GGZ Standaarden · GGZ Standaarden (Akwa GGZ) · 2017

Norwegen· 2

• National clinical guideline for the treatment of psychotic disorders - drug treatment

  Hdir · Norwegian Directorate of Health · 2026

• National Clinical Guideline for Medication Treatment of Psychotic Disorders

  Helsedir · Norwegian Directorate of Health · 2025

Polen· 1

• Recommendations for the Treatment of Schizophrenia with Negative Symptoms - Pharmacotherapy Standards of the Polish Psychiatric Association, Part 1

  PTP · Polskie Towarzystwo Psychiatryczne · 2019 · recommendation

Portugal· 1

• Pharmacological Treatment of Major Depression and its Recurrence in Adults

  DGS · Direcao-Geral da Saude · 2012

Spanien· 2

• Clinical Practice Guideline for the Treatment of Generalised Anxiety Disorder in Primary Care

  GuiaSalud · Servicio de Evaluacion del Servicio Canario de la Salud / Ministerio de Sanidad · 2024

• Clinical Practice Guideline on the Management of Depression in Adults

  GuiaSalud · Agencia de Conocimiento en Salud (Avalia-t) / Ministerio de Sanidad · 2023

Schweden· 2

• National Guidelines for Care of Depression and Anxiety Disorders - Support for Governance and Management

  Socialstyrelsen · National Board of Health and Welfare · 2021

• National Guidelines for Care and Support in Schizophrenia and Schizophrenia-like Conditions - Support for Governance and Management

  Socialstyrelsen · National Board of Health and Welfare · 2018

Vereinigtes Königreich· 8

• Depression in Adults: Treatment and Management

  NICE · National Institute for Health and Care Excellence · 2022

• Post-traumatic Stress Disorder

  NICE · National Institute for Health and Care Excellence · 2018

• Eating Disorders: Recognition and Treatment

  NICE · National Institute for Health and Care Excellence · 2017

• Psychosis and Schizophrenia in Adults: Prevention and Management

  NICE · National Institute for Health and Care Excellence · 2014

• Bipolar Disorder: Assessment and Management

  NICE · National Institute for Health and Care Excellence · 2014

• Generalised Anxiety Disorder and Panic Disorder in Adults: Management

  NICE · National Institute for Health and Care Excellence · 2011

• Drug Misuse in Over 16s: Psychosocial Interventions

  NICE · National Institute for Health and Care Excellence · 2007

• Drug Misuse in Over 16s: Opioid Detoxification

  NICE · National Institute for Health and Care Excellence · 2007